Skip to search formSkip to main contentSkip to account menu

60 ACTUAT Budesonide 0.09 MG/ACTUAT Dry Powder Inhaler [Pulmicort]

Known as: Pulmicort Flexhaler 90 MCG/INHAL Dry Powder Inhaler, 60 ACTUAT, Pulmicort Flexhaler 0.09 MG/ACTUAT (0.08 MG/ACTUAT from the mouthpiece) Dry Powder Inhaler, 60 ACTUAT, BUDESONIDE 90 ug RESPIRATORY (INHALATION) AEROSOL, POWDER [PULMICORT FLEXHALER] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background: The development of accurate in vitro-in vivo correlations requires the consideration of a number of factors in vitro… 
2017
2017
This work investigated the effect of relative humidity (RH) on bipolar electrostatic charge profiles of dry powder inhaler… 
Highly Cited
2010
Highly Cited
2010
The aim of this work was to evaluate the in vitro performance of a nebulized nanoemulsion formulation which had been optimised… 
2007
2007
Objective:To investigate the clinical effects of inhalation of asarone mixed with pulmicort respules which as an assistant method… 
2005
2005
Aim To assess the effect of Pulmicort Respules and Bricanyl Nebulising Solution inhaled in the treatment of asthma in children… 
2004
2004
The aim of this study was to compare the clinical efficacy, safety, and acceptability of budesonide inhaled from Easyhaler dry… 
2003
2003
Assessment of adrenal suppression via systemic cortisol levels provides an indirect measure of the lung delivery of inhaled… 
2002
2002
Background and Objectives: To investigate the therapeutic equivalence of the two formulations of the glucocorticosteroid…